BioLight Life Sciences Ltd.
Company Details
Status: Public
Employees: 1-10
Location:
2234 Street, Park Atidim, Building 7, 2nd floor, Tel Aviv, 6158101, IL
Type:
sample
sample
sample
sample
Technology:
About: BioLight Life Sciences Ltd. is an Israel-based company dedicated to investing in and managing projects focused on eye diseases and ocular treatments. As the only company in Israel specializing exclusively in ophthalmology, BioLight is a leader in this field. It is publicly traded on the Tel Aviv Stock Exchange under the ticker symbol BOLT.
The company’s portfolio includes advanced medical devices, medications, diagnostics, and digital medicine aimed at addressing significant needs in ophthalmology. BioLight develops and commercializes products that enhance diagnosis and treatment efficacy for various eye conditions, including glaucoma, dry eye syndrome, and age-related macular degeneration. A notable product is the Eye-D platform, an insertable device designed for the controlled release of ophthalmic medications, which helps improve patient compliance with treatments.
BioLight's strategy focuses on expanding its portfolio of ophthalmic technologies, particularly those integrating digital medicine. The company collaborates with a global network of ophthalmic specialists to identify medical needs and assess potential technologies, positioning itself as a key player in the ophthalmology sector both in Israel and internationally.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
BioLight Life Sciences Ltd. | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.